Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08NXW
|
||||
Former ID |
DIB010220
|
||||
Drug Name |
GLP-1
|
||||
Synonyms |
Oral GLP (diabetes, eligen), Emisphere; GLP-1 (oral tablet, Eligen, diabetes); Glucagon-like peptides (oral, eligen), Emisphere; GLP-1 (oral tablet, Eligen, diabetes), Emisphere
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Phase 3 | [549904] | ||
Company |
Emisphere Technologies Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C149H226N40O45
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Glucagon-like peptide 1 receptor | Target Info | Modulator | [543638] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.